Session

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie)

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Getting a measure on the true impact of Crohn’s disease
Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Getting a measure on the true impact of Crohn’s disease

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie)

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Inhibition of IL-23: a pathway worth exploring
Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Inhibition of IL-23: a pathway worth exploring

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie)

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Broadening the horizon of CD: where are we, where are we going and what role could IL-23 play?
Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Broadening the horizon of CD: where are we, where are we going and what role could IL-23 play?

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie)

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Welcome and introduction
Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Welcome and introduction

Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie)

Item 1 - 4 / 4
1